Inventor · disambiguated record
Remi Meyrueix
Also filed as: MEYRUEIX REMI · MEYRUEIX RÉMI
28 granted patents·24 pending applications·920 citations·filing 1989–2017
97Inventor score
Files withFLAMEL TECH SA16FLAMEL TECHNOLOGIES S A6RHONE POULENC CHIMIE4CASTAN CATHERINE3FLAMEL IRELAND LTD3
Top patents by PatentIndex Score
52 records- 0198USRE47084EOral medicinal product with modified release of at least one active principle in multimicrocapsular formFLAMEL IRELAND LTD·Filed 2016·Granted Oct 16, 2018·36 cites·74 claims
- 0298US9814684B2Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s)FLAMEL IRELAND LTD·Filed 2015·Granted Nov 14, 2017·36 cites·31 claims
- 0398US7906145B2Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s)FLAMEL TECH SA·Filed 2003·Granted Mar 15, 2011·101 cites·25 claims
- 0497US10004693B2Oral pharmaceutical formulation in the form of aqueous suspension for modified release of active principle(s)CASTAN CATHERINE·Filed 2011·Granted Jun 26, 2018·36 cites·24 claims
- 0597US7879362B2Oral pharmaceutical compositions with controlled release and prolonged absorptionFLAMEL TECH SA·Filed 2007·Granted Feb 1, 2011·51 cites·21 claims
- 0694US8101209B2Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principlesLEGRAND VALERIE·Filed 2004·Granted Jan 24, 2012·132 cites·17 claims
- 0792US8652523B2Oral pharmaceutical formulation in the form of a plurality of microcapsules for prolonged release of active principle(s) with slow solubilityGUIMBERTEAU FLORENCE·Filed 2003·Granted Feb 18, 2014·42 cites·14 claims
- 0891US10052289B2Composition comprising an active agent with low aqueous solubilityMEYRUEIX REMI·Filed 2009·Granted Aug 21, 2018·36 cites·38 claims
- 0991US8734850B2Oral medicinal product with modified release of at least one active principle in multimicrocapsular formCASTAN CATHERINE·Filed 2004·Granted May 27, 2014·39 cites·28 claims
- 1088US5811507APolyesterimides for use in linear and/or non-linear optics, and one method for preparing sameFLAMEL TECH SA·Filed 1994·Granted Sep 22, 1998·45 cites·28 claims
- 1187US6133199AProcess and compositions promoting biological effectiveness of exogenous chemical substances in plantsMONSANTO CO·Filed 1998·Granted Oct 17, 2000·42 cites·39 claims
- 1286US8084045B2Pharmaceutical formulations for the prolonged release of active principle(s) and their applicationsPOULIQUEN GAUTHIER·Filed 2004·Granted Dec 27, 2011·37 cites·24 claims
- 1386US6790438B1Cross-linked collagenic peptide for preventing post-surgical adhesionsFLAMEL TECH SA·Filed 2000·Granted Sep 14, 2004·55 cites·27 claims
- 1484US6180141B1Composite gel microparticles as active principle carriersFLAMEL TECH SA·Filed 1997·Granted Jan 30, 2001·78 cites·21 claims
- 1580US7910133B2Oral pharmaceutical formulation in the form of aqueous suspension of microcapsules for modified release of amoxicillinFLAMEL TECH SA·Filed 2003·Granted Mar 22, 2011·8 cites·24 claims
- 1680US5535048ANonlinearly optically active compoundsFLAMEL TECH SA·Filed 1994·Granted Jul 9, 1996·16 cites·21 claims
- 1779US8236353B2Self-precipitating pharmaceutical formulations for the modified release of an active principleCHECOT FREDERIC·Filed 2008·Granted Aug 7, 2012·4 cites·14 claims
- 1879US8197850B2Medicine based on anti-hyperglycaemic microcapsules with prolonged release and method for preparing sameCASTAN CATHERINE·Filed 2001·Granted Jun 12, 2012·9 cites·18 claims
- 1976US6001958ACrosslinkable polymer, particularly for optical and non-linear optical use, materials or devices using same, and method for preparing said polymerFLAMEL TECH SA·Filed 1994·Granted Dec 14, 1999·22 cites·20 claims
- 2074US6500783B1Process and compositions promoting biological effectiveness of exogenous chemical substances in plantsMONSANTO TECHNOLOGY LLC·Filed 1999·Granted Dec 31, 2002·21 cites·49 claims
- 2169US4985528ANovel nonlinearly optically active polyurethanesRHONE POULENC CHIMIE·Filed 1989·Granted Jan 15, 1991·26 cites·15 claims
- 2266US5359072ANonlinearly optically active compoundsRHONE POULENC CHIMIE·Filed 1991·Granted Oct 25, 1994·7 cites·11 claims
- 2366US2017281558A1Oral pharmaceutical formulation in the form of an aqueous suspension of microcapsules for the modified release of active principle(s).FLAMEL IRELAND LTD·Filed 2017·Application pending·0 cites
- 2465US2007173464A1Oral ribavirin pharmaceutical compositionsFLAMEL TECH SA·Filed 2007·Application pending·0 cites
- 2564US2010021549A1Microparticle oral form useful for the modified release of nanoparticlesFLAMEL TECHNOLOGIES S A·Filed 2009·Application pending·0 cites
- 2661US2007166378A1Oral ribavirin pharmaceutical compositionsFLAMEL TECHNOLOGIES INC·Filed 2006·Application pending·0 cites
- 2761US2010266701A1Anti-misuse microparticulate oral drug formFLAMEL TECHNOLOGIES S A·Filed 2009·Application pending·0 cites
- 2859US2006275376A1Microcapsules with modified release of active principles with low solubility for oral deliveryGUIMBERTEAU FLORENCE·Filed 2003·Application pending·0 cites
- 2958US8017156B2Long-acting colloidal insulin formulation and its preparationFLAMEL TECH SA·Filed 2005·Granted Sep 13, 2011·0 cites·12 claims
- 3058US5156774AThiophene-related compounds active in nonlinear optics, materials and devices containing themFLAMEL TECH SA·Filed 1990·Granted Oct 20, 1992·20 cites·15 claims
- 3155US2009220611A1Microparticles With Modified Release of At Least One Active Principle and Oral Pharmaceutical Form Comprising SameDARGELAS FREDERIC·Filed 2006·Application pending·0 cites
- 3254US2009311315A1Multimicroparticulate Oral Pharmaceutical Form with Modified Release of Angiotensin II Receptor AntagonistsFLAMEL TECHNOLOGIES S A·Filed 2006·Application pending·0 cites
- 3354US2011129539A1Oral pharmaceutical formulation in the form of an aqueous suspension of microcapsules for modified release of amoxicillinFLAMEL TECH SA·Filed 2011·Application pending·0 cites
- 3453US5189134ANonlinearly optically active polymersRHONE POULENC CHIMIE·Filed 1989·Granted Feb 23, 1993·11 cites·10 claims
- 3553US2004022849A1Oral pharmaceutical composition with controlled release and prolonged absorptionFiled 2001·Application pending·0 cites
- 3653US2010068291A1Oral Medicament Based on a Proton Pump InhibitorFLAMEL TECHNOLOGIES S A·Filed 2006·Application pending·0 cites
- 3752US5324827AOptionally oriented, monomeric and polymeric nonlinearly optically active materials and derivatives thereofFLAMEL TECH SA·Filed 1993·Granted Jun 28, 1994·3 cites·8 claims
- 3852US2004208936A1Novel compositionsFiled 2003·Application pending·0 cites
- 3952US2009041838A1Anti-Misuse Microparticulate Oral Drug FormFLAMEL TECHNOLOGIES S A·Filed 2006·Application pending·0 cites
- 4051US2008026056A1Antibiotic-Based Pharmaceutical Formulation in Microcapsular FormFLAMEL TECH SA·Filed 2005·Application pending·0 cites
- 4149US5075409AOrganic material active in nonlinear opticsRHONE POULENC CHIMIE·Filed 1990·Granted Dec 24, 1991·7 cites·38 claims
- 4248US2007218142A1Pharmaceutical Formulations For The Prolonged Release Of Interleukins And Their Therapeutic ApplicationsBIGNON SOPHIE·Filed 2004·Application pending·0 cites
- 4346US2007269517A1Pharmaceutical Formulations for the Prolonged Release of Interferons and Their Therapeutic ApplicationsFLAMEL TECHNOLOGIES INC·Filed 2004·Application pending·0 cites
- 4444US2012156256A1Nanoparticles having at least one active ingredient and at least two polyelectrolytesBONNET-GONNET CECILE·Filed 2011·Application pending·0 cites
- 4544US2009123536A1Oral Pharmaceutical Form of LosartanFLAMEL TECHNOLOGIES S A·Filed 2006·Application pending·0 cites
- 4643US2012294832A1Composition comprising interferon alphaPOULIQUEN GAUTHIER·Filed 2012·Application pending·0 cites
- 4743US2008305160A1Oral Medicament For The Modified Release Of At Least One Active Principle, In Multimicrocapsule FormFLAMEL TECH SA·Filed 2005·Application pending·0 cites
- 4842US2004219212A1Single-daily dose antidiabetic oral pharmaceutical form comprising a biguanide and at least another active principleFiled 2002·Application pending·0 cites
- 4942US2005037077A1Galenic microparticulate oral formulation for delayed and controlled release of pharmaceutical active principlesFiled 2002·Application pending·0 cites
- 5041US2006165808A1Microcapsules for the delayed, controlled release of perindoprilHUET DE BAROCHEZ BRUNO·Filed 2003·Application pending·0 cites
Showing the top 50 of 52 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →